Study shows convalescent plasma works for COVID-19 patients
“This is really important because these people can be treated, and they could have better outcomes with this material if we can just get the word out.”
Stay updated with breaking news from Plasma Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“This is really important because these people can be treated, and they could have better outcomes with this material if we can just get the word out.”
Convalescent plasma -- a once-celebrated treatment for Covid-19 that has largely fallen out of favor -- does work well for people who are immune-compromised, according to a study published Thursday.
While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.
As more and more people survive the new coronavirus, hospitals want them to line up to donate some blood
A discussion has opened in the science world over whether convalescent plasma treatments are effective at preventing death and creating better outcomes for patients.